InsiderTrades

Form 4 for AVIR Atea Pharmaceuticals, Inc.

Accepted 2026-06-23 17:00:06 ET · period of report 2026-06-18 · accession 0001193125-26-279718 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-23 17:00 2026-06-18 AVIR Murphy Polly A. Dir M - OptEx $0.00 +29.6K 121.7K +32% $0
D 2026-06-23 17:00 2026-06-18 AVIR Murphy Polly A. Dir M - OptEx $0.00 -29.6K 0 -100% $0
DM 2026-06-23 17:00 2026-06-18 AVIR Murphy Polly A. Dir A - Grant $0.00 +64.4K 37.7K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-18 M A 29,600 $0.00 121,745 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2 Derivative Restricted Stock Units 2026-06-18 M D 29,600 $0.00 0 D — · — to — 29,600 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) The RSUs vested in full on June 18, 2026. (F2) The RSUs vested in full on June 18, 2026.
3 Derivative Restricted Stock Units 2026-06-18 A A 26,700 $0.00 26,700 D — · — to — 26,700 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. (F3) The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
4 Derivative Stock Option (Right to Buy) 2026-06-18 A A 37,700 $0.00 37,700 D $4.36 · — to 2036-06-17 37,700 Common Stock (F4) The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.